Request for Covid-19 Impact Assessment of this Report
The CLOT study, published in 2003, showed that in patients with malignancy and acute venous thromboembolism, dalteparin was more effective than warfarin in reducing the risk of recurrent embolic events. Dalteparin is not superior to unfractionated heparin in preventing blood clots.
Heparins are cleared by the kidneys, but studies have shown that dalteparin does not accumulate even if kidney function is reduced.
This report provides detailed analysis of worldwide markets for Dalteparin Sodium from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Dalteparin Sodium market and further lays out an analysis of the factors influencing the supply/demand for Dalteparin Sodium, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Dalteparin Sodium Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Dalteparin Sodium market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Dalteparin Sodium market are Pfizer (USA), Reliable Biopharmaceutical (USA), Gland Pharma (India), Opocrin (Italy), Hebei Changshan (China), Changzhou Qianhong (China), Nanjing Kingfriend (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Dalteparin Sodium industry has been provided.
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario
Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application
Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies
Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
List Of Tables
Figure Global Dalteparin Sodium Production Volume (Unit) 2011-2016
Figure Global Dalteparin Sodium Production Value (M USD) 2011-2016
Figure Top 10 Dalteparin Sodium Vendors Production Volume Share 2015
Figure Top 10 Dalteparin Sodium Vendors Production Value Share 2015
Figure Regional Dalteparin Sodium Production (Unit) 2015
Figure Regional Dalteparin Sodium Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Dalteparin Sodium Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Dalteparin Sodium Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Dalteparin Sodium Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Dalteparin Sodium Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Dalteparin Sodium Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Dalteparin Sodium Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Dalteparin Sodium Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Dalteparin Sodium Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Dalteparin Sodium Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Dalteparin Sodium Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Dalteparin Sodium Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Dalteparin Sodium Vendors Production (Unit) 2011-2016
Table Global Key Dalteparin Sodium Vendors Production Share 2011-2016
Figure Global Dalteparin Sodium Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2011-2016
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2011
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2012
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2013
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2014
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2015
Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2016
Figure Dalteparin Sodium Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Dalteparin Sodium Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Dalteparin Sodium Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Dalteparin Sodium Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Dalteparin Sodium Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Dalteparin Sodium Production Value (M USD), Growth Rate
Table Global Key Dalteparin Sodium Vendors Production Value (M USD) 2011-2016
Table Global Key Dalteparin Sodium Vendors Production Value Share 2011-2016
Figure Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2011
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2012
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2013
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2014
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2015
Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2016
Figure Dalteparin Sodium Prices (USD/Ton) 2016
Figure Dalteparin Sodium Gross Margin 2016
Figure Dalteparin Sodium Production Value (M USD) By Region 2011-2016
Table Global Dalteparin Sodium Production Value (M USD) 2011-2016
Table Global Dalteparin Sodium Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Dalteparin Sodium Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Dalteparin Sodium Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Dalteparin Sodium Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Dalteparin Sodium Production Value Share Trend
Figure Global Dalteparin Sodium Consumption Volume (Unit) 2015
Table Regional Dalteparin Sodium Consumption Volume (Unit) 2011-2016
Table Regional Dalteparin Sodium Consumption Volume Share 2011-2016
Figure Dalteparin Sodium Consumption in North America 2011-2016
Figure Dalteparin Sodium Consumption in EMEA 2011-2016
Figure Dalteparin Sodium Consumption in Asia-Pacific 2011-2016
Figure Dalteparin Sodium Consumption in ROW 2011-2016
Figure Global Dalteparin Sodium Consumption Volume (Unit) 2016
Table Global Dalteparin Sodium Consumption Volume (Unit) 2011-2016
Table Global Dalteparin Sodium Consumption Volume Share 2011-2016
Figure Global Dalteparin Sodium Production (Unit) Forecast 2016-2021
Table Global Dalteparin Sodium Production (Unit) 2016-2021
Table Global Dalteparin Sodium Production Share 2016-2021
Figure North Dalteparin Sodium Production (Unit) Forecast 2016-2021
Figure EMEA Dalteparin Sodium Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Dalteparin Sodium Production (Unit) Forecast 2016-2021
Figure ROW Dalteparin Sodium Production (Unit) Forecast 2016-2021
Figure Global Dalteparin Sodium Revenue (M USD) Forecast 2016-2021
Table Global Dalteparin Sodium Revenue (M USD) 2016-2021
Table Global Dalteparin Sodium Revenue Share 2016-2021
Figure North America Dalteparin Sodium Revenue (M USD) Forecast 2016-2021
Figure EMEA Dalteparin Sodium Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Dalteparin Sodium Revenue (M USD) Forecast 2016-2021
Figure ROW Dalteparin Sodium Revenue (M USD) Forecast 2016-2021
Figure Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021
Table Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021
Table Global Dalteparin Sodium Consumption Volume Share 2016-2021
Figure North America Dalteparin Sodium Consumption (Unit) Forecast
Figure EMEA Dalteparin Sodium Consumption (Unit) Forecast
Figure Asia-Pacific Dalteparin Sodium Consumption (Unit) Forecast
Figure ROW Dalteparin Sodium Consumption (Unit) Forecast
Figure Global Dalteparin Sodium Consumption Volume (Unit) 2021
Table Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021
Table Global Dalteparin Sodium Consumption Volume Share 2016-2021
Table Key Strategies for Dalteparin Sodium Multinational Corporations
Table Key Strategies for Dalteparin Sodium Emerging-Market Players
List Of Figures
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...